Endocrine therapies for sarcopenia in older men.
This review looks at new therapeutic developments for the increasingly recognized problem of sarcopenia. Increased adiposity and reduced lean body mass characterize ageing men. The potential therapeutic role of the growth hormone/insulin-like growth factor axis, androgen modulators and myostatin inhibition are discussed.